Podcast: Alternative testing models to shape toxicology “with time”
Annabel Kartal-Allen chats with Charles River's Head of GLBL Toxicology, Steve Bulera, about the current state of the alternative testing space, the sector's future trajectory and the hurdles that must...

Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal